FCM Stock Overview
Friulchem S.p.A. engages in the research, development, and production of original and generic pharmaceutical products for human and veterinary use in Italy.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Friulchem S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.93 |
| 52 Week High | €1.21 |
| 52 Week Low | €0.89 |
| Beta | 0.55 |
| 1 Month Change | -5.10% |
| 3 Month Change | -7.00% |
| 1 Year Change | -12.26% |
| 3 Year Change | -20.85% |
| 5 Year Change | n/a |
| Change since IPO | -46.61% |
Recent News & Updates
Shareholder Returns
| FCM | IT Pharmaceuticals | IT Market | |
|---|---|---|---|
| 7D | -1.6% | 0.4% | 1.3% |
| 1Y | -12.3% | 9.8% | 20.1% |
Return vs Industry: FCM underperformed the Italian Pharmaceuticals industry which returned 9.8% over the past year.
Return vs Market: FCM underperformed the Italian Market which returned 20.1% over the past year.
Price Volatility
| FCM volatility | |
|---|---|
| FCM Average Weekly Movement | 2.9% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in IT Market | 7.8% |
| 10% least volatile stocks in IT Market | 2.8% |
Stable Share Price: FCM has not had significant price volatility in the past 3 months.
Volatility Over Time: FCM's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 86 | Disma Mazzola | www.friulchem.com |
Friulchem S.p.A. engages in the research, development, and production of original and generic pharmaceutical products for human and veterinary use in Italy. It offers generic cosmoceuticals and food supplements; and chewable cubes for animals. The company was founded in 1996 and is based in Milan, Italy.
Friulchem S.p.A. Fundamentals Summary
| FCM fundamental statistics | |
|---|---|
| Market cap | €5.58m |
| Earnings (TTM) | -€299.00k |
| Revenue (TTM) | €31.09m |
0.2x
P/S Ratio-18.7x
P/E RatioIs FCM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FCM income statement (TTM) | |
|---|---|
| Revenue | €31.09m |
| Cost of Revenue | €24.04m |
| Gross Profit | €7.05m |
| Other Expenses | €7.35m |
| Earnings | -€299.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.05 |
| Gross Margin | 22.69% |
| Net Profit Margin | -0.96% |
| Debt/Equity Ratio | 126.0% |
How did FCM perform over the long term?
See historical performance and comparison